Literature DB >> 22573561

Dissolution profile of novel composite pellet cores based on different ratios of microcrystalline cellulose and isomalt.

Oliver Luhn1, Nikolett Kállai, Zsombor Kristóf Nagy, Kristóf Kovács, Bodo Fritzsching, Imre Klebovich, István Antal.   

Abstract

There is a growing interest towards the application of inert cores as starting materials for pharmaceutical pellet manufacturing. They serve as alternatives to develop and adapt a relatively simple manufacturing technology compared with an extrusion/spheronisation process. The major objective of this study was to investigate the effect of the compositions of core materials on the drug release profile. Pure microcrystalline cellulose (MCC), isomalt and different types of novel composite MCC-isomalt cores were layered with model drug (sodium diclofenac) and were coated with acrylic polymer. The effect of the osmolality in the gastrointestinal tract was simulated using glucose as osmotically active agent during in vitro dissolution tests. The results demonstrated the dependence of drug dissolution profile on the ratio of MCC and isomalt in the core and the influence of osmotic properties of the dissolution medium. Isomalt used in the composite core was able to decrease the vulnerability of the dissolution kinetics to the changes in the osmotic environment.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573561     DOI: 10.1002/jps.23186

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

Review 1.  Review on Starter Pellets: Inert and Functional Cores.

Authors:  Nikolett Kállai-Szabó; Miléna Lengyel; Dóra Farkas; Ádám Tibor Barna; Christian Fleck; Bálint Basa; István Antal
Journal:  Pharmaceutics       Date:  2022-06-18       Impact factor: 6.525

2.  Development of a Biphasic-Release Multiple-Unit Pellet System with Diclofenac Sodium Using Novel Calcium Phosphate-Based Starter Pellets.

Authors:  Daniel Zakowiecki; Maja Frankiewicz; Tobias Hess; Krzysztof Cal; Maciej Gajda; Justyna Dabrowska; Bartlomiej Kubiak; Jadwiga Paszkowska; Marcela Wiater; Dagmara Hoc; Grzegorz Garbacz; Dorota Haznar-Garbacz
Journal:  Pharmaceutics       Date:  2021-05-28       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.